Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Ovarian and testicular damage by cytotoxic drugs.

Oommen R, Jose CC, Vishwanathan F, Roul RK, Singh AD.

Indian J Cancer. 1991 Sep;28(3):119-23.

PMID:
1786977
2.
3.
4.

Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection.

Damani MN, Master V, Meng MV, Burgess C, Turek P, Oates RD.

J Clin Oncol. 2002 Feb 15;20(4):930-6. Erratum in: J Clin Oncol 2002 Aug 1;20(15):3361. Masters V [corrected to Master V].

PMID:
11844813
5.

Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.

Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM.

J Clin Oncol. 1995 Jan;13(1):134-9.

PMID:
7799013
6.

Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease.

Kreuser ED, Xiros N, Hetzel WD, Heimpel H.

J Cancer Res Clin Oncol. 1987;113(3):260-6.

PMID:
3108263
7.

Male gonadal function after chemotherapy in survivors of childhood malignancy.

Mustieles C, Muñoz A, Alonso M, Ros P, Yturriaga R, Maldonado S, Otheo E, Barrio R.

Med Pediatr Oncol. 1995 Jun;24(6):347-51.

PMID:
7715540
8.

The effects of etoposide on testicular function in boys treated for Hodgkin's disease.

Gerres L, Brämswig JH, Schlegel W, Jürgens H, Schellong G.

Cancer. 1998 Nov 15;83(10):2217-22.

PMID:
9827728
9.

Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.

Rafsanjani KA, Faranoush M, Hedayatiasl AA, Vossough P.

Saudi Med J. 2007 Nov;28(11):1690-3.

PMID:
17965791
10.

[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].

Soriano Guillén L, Muñoz Calvo MT, Pozo Román J, Contra Gómez T, Buño Soto M, Argente Oliver J.

An Esp Pediatr. 2000 Oct;53(4):318-23. Spanish.

PMID:
11083980
11.

Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy.

Waxman JH, Terry YA, Wrigley PF, Malpas JS, Rees LH, Besser GM, Lister TA.

Br Med J (Clin Res Ed). 1982 Dec 4;285(6355):1612-3.

12.

Gonadal function in young patients successfully treated for Hodgkin disease.

Papadakis V, Vlachopapadopoulou E, Van Syckle K, Ganshaw L, Kalmanti M, Tan C, Sklar C.

Med Pediatr Oncol. 1999 May;32(5):366-72.

PMID:
10219339
13.

Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.

Bordallo MA, Guimarães MM, Pessoa CH, Carriço MK, Dimetz T, Gazolla HM, Dobbin J, Castilho IA.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):879-87.

PMID:
15270406
14.

Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.

Pectasides D, Pectasides E, Papaxoinis G, Skondra M, Gerostathou M, Karageorgopoulou S, Kamposioras C, Tountas N, Koumarianou A, Psyrri A, Macheras A, Economopoulos T.

J Androl. 2009 May-Jun;30(3):280-6. doi: 10.2164/jandrol.108.006437. Epub 2009 Jan 8.

15.

Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.

Tsatsoulis A, Shalet SM, Morris ID, de Kretser DM.

Horm Res. 1990;34(5-6):254-9.

PMID:
2129227
16.

Effect of cancer therapy on pituitary-testicular axis.

Howell SJ, Shalet SM.

Int J Androl. 2002 Oct;25(5):269-76. Review.

PMID:
12270023
17.

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.

Badawy A, Elnashar A, El-Ashry M, Shahat M.

Fertil Steril. 2009 Mar;91(3):694-7. doi: 10.1016/j.fertnstert.2007.12.044. Epub 2008 Aug 3.

PMID:
18675959
18.

Effect of cytotoxic therapy on sexuality and gonadal function.

Chapman RM.

Semin Oncol. 1982 Mar;9(1):84-94.

PMID:
6176028
19.

The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease.

Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG.

Cancer. 1983 Sep 15;52(6):988-93.

20.

[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study].

Kreuser ED, Kurrle E, Hetzel WD, Heymer B, Porzsolt F, Hautmann R, Gaus W, Schlipf U, Pfeiffer EF, Heimpel H.

Klin Wochenschr. 1989 Apr 3;67(7):367-78. German.

PMID:
2501552
Items per page

Supplemental Content

Write to the Help Desk